Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

Objective. IFN α Kinoid (IFN-K) is a therapeutic vaccine composed of IFNα2b coupled to a carrier protein. In a phase I/II placebo-controlled trial, we observed that IFN-K significantly decreases the IFN gene signature in whole blood RNA samples from SLE patients. Here, we analysed extended follow-up...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Rheumatology (Oxford)
Glavni autori: Ducreux, Julie, Houssiau, Frédéric A., Vandepapelière, Pierre, Jorgensen, Christian, Lazaro, Estibaliz, Spertini, François, Colaone, Fabien, Roucairol, Camille, Laborie, Marion, Croughs, Thérèse, Grouard-Vogel, Géraldine, Lauwerys, Bernard R.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Basic Science
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034220/
https://ncbi.nlm.nih.gov/pubmed/27354683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kew262
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items